The Importance of a Single-Point-of-Contact Model for Patient Engagement

In our September Patient Services Report, Momentum Life Sciences discussed the single-point-of-contact (SPOC) model for patient engagement programs in the biopharma industry and what makes this such an effective way to enhance the patient experience, boost outcomes, and increase efficiencies for our clients.

Patient Engagement and Human Connection: Addressing the Chronic Disease Management Crisis

The importance of human connection in patient engagement remains paramount to building trusted relationships. There is a significant need for SPOC support, as 85% of healthcare costs are related to chronic disease care. In addition, 50% of the population is impacted by a chronic disease, and 91% of patients [reference] say they need more help managing their condition.

patient engagement - 50% of the population is affected by chronic disease

50%

of the population is affected by chronic disease1

patient engagement - 85% of healthcare costs are related to chronic disease care

85%

of healthcare costs are related to chronic disease care1

patient engagement - 91% of patients need more help with chronic disease management

91%

of patients said they need more help with chronic disease management2

Patient Engagement Challenges: Navigating Stakeholder Complexity in Chronic Illness Management

Self-managing a chronic illness can be challenging and confusing for most people. In addition to navigating the fear and emotions surrounding their diagnosis and therapy, patients are also expected to interface with many different stakeholders. Each of these stakeholders is responsible for monitoring and supporting a different aspect of the patient’s health. Rarely does any one particular party serve as a consistent point of contact for the patient, and it can be difficult to determine which party to contact for which issue.

The SPOC Model: Revolutionizing Patient Engagement Strategies with Streamlined Support and Holistic Care Benefits

As the market continues to shift toward patient-centric healthcare, a new model is needed to help support the patient. The SPOC model is becoming increasingly popular and important for patient engagement, as it localizes the different stakeholders to just one contact making the therapy journey for patients easier because they receive communication, support, and education through a single channel.

The Benefits of Improving Patient Engagement

SPOC Benefits for Patients

Enhanced Coordination: Seamless communication and collaboration among parties

Personalized Support: Support tailored to individual patient needs

Improved Treatment Outcomes: Optimized medication adherence and treatment monitoring, with timely adjustments

Patient Empowerment: Constant encouragement from a knowledgeable champion, providing increased patient confidence and motivation

Holistic Approach: Considers aspects of the patient’s well-being (eg, physical, emotional, and social factors) to improve patient quality of life

SPOC Benefits for BioPharma

Improved Experience: A coordinated and cohesive support model that improves patient and HCP perceptions of the brand and pharma company

Brand Performance: Greater revenue driven by a reduction in patient abandonment and increased patient adherence

Cost Efficiencies: Streamlined support that reduces redundant activities and resources

Proven Success of the SPOC Model: Boosting Patient Engagement and Reducing Medical Costs in Pharma

In rolling out a SPOC model, some pharma companies have already seen positive impacts including an 81% increase in patient engagement3 and 2%-7% in medication adherence5 because patients are more connected. Manufacturers have also seen a decrease in medication abandonment (14%)4 and overall medical costs (23%)4. As this model continues to be adopted, additional benefits will be manifest.

Proven Impact of SPOC in Pharma

99%

patient acceptance of PPC support models4

Patient support with a SPOC model vs. without a SPOC model:

patient engagement

81% INCREASE
in patient engagement3

14% REDUCTION
in medication abandonment
4

increasing medication adherence

2-7% INCREASE
in medication adherence5

23% REDUCTION
in medical costs4

References:

1. NCBI. 2. Learning&Learning. 3. Carenet Health. 4. Pharma Exec. 5. Patient Engagement Hit.

Latest posts

  • rare disease support

    Three Pillars of Rare Disease Support: Building an Essential Network

    Discover the three essential pillars of rare disease support: medical expertise, community connections, and family engagement. Learn how integrating these elements creates comprehensive support networks for the 1 in 1,500 Americans affected by rare diseases.

  • oncology and medication adherence

    Oncology and Medication Adherence

    Motivated patients are more likely to have better adherence and outcomes. Healthcare providers (HCPs) and families play crucial roles in treatment. Cancer mortality has significantly dropped over time, but nonadherence continues to be a problem. This is particularly so for patients taking oral oncolytics.

  • the importance of measuring patient engagement

    Measuring Patient Engagement Success

    Measuring success in any endeavor requires a metric and scale by which to measure. Once this is determined, a method must be developed to determine how a company’s efforts rate.

  • importance of emotional support provided by biopharma

    Patient Engagement and Emotional Support

    Biopharma companies offer many forms of support when therapy is initiated. Substantial research indicates people with rare or complex conditions require a more intensive level of support that includes addressing the emotional needs related to their condition.